FUNDAMENTALS |
MarketCap: |
98 673 mill
|
EPS: |
12.17
|
P/E: |
28.54
|
Earnings Date: |
Aug 01, 2024 |
SharesOutstanding: |
284.07 mill
|
Avg Daily Volume: |
1.487 mill
|
RATING
2024-05-08 |
B+
|
Neutral
|
RATINGS |
Rating CashFlow: |
Strong Buy
|
|
Return On Equity: |
Sell
|
|
Return On Asset: |
Sell
|
|
DE: |
Strong Buy
|
|
P/E: |
Strong Sell
|
|
Price To Book: |
Neutral
|
|
QUARTER GROWTHS |
|
4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 |
Revenue | | | | | | |
Gr.Profit | | | | | | |
Ebit | | | | | | |
Asset | | | | | | |
Debt | | | | | | |
PE RATIO: COMPANY / SECTOR |
1.85x
|
Company: PE 28.54 | sector: PE 15.43
|
PE RATIO: COMPANY / INDUSTRY |
1.13x
|
Company: PE 28.54 | industry: PE 25.16
|
DISCOUNTED CASH FLOW VALUE |
$803.79
(131.41%)
$456.44
|
Date: 2024-05-08
|
Expected Trading Range (DAY) |
$ 341.90 - 352.80
( +/- 1.57%)
|
ATR Model: 14 days
|
Insider Trading
Date |
Person |
Action |
Amount |
type |
2024-04-24 | Wiseman Eric C | Buy | 539 | Common Stock, $.01 Par Value |
2024-04-24 | Ozuah Philip | Buy | 539 | Common Stock, $.01 Par Value |
2024-04-24 | Mcclellan Mark B. | Buy | 539 | Common Stock, $.01 Par Value |
2024-04-24 | Kurian George | Buy | 539 | Common Stock, $.01 Par Value |
2024-04-24 | Zarcone Donna F | Buy | 539 | Common Stock, $.01 Par Value |
INSIDER POWER |
11.06
|
Last
100 transactions |
Buy:
329 505 | Sell:
261 993 |
Forecast:
16:00 - $347.41
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $347.41
Forecast 2: 16:00 - $347.41
Forecast 3: 16:00 - $347.41
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals |
RSI 21 |
|
SMA |
|
Trend |
|
Trend 2 |
|
Trend 3 |
|
MACD |
|
Volume Signals |
Price |
$347.35 (0.19% )
|
Volume |
1.279 mill
|
Avg. Vol. |
1.487 mill
|
% of Avg. Vol |
86.01 %
|
Signal 1: |
|
Signal 2: |
|
Last 10 Buy & Sell Signals For CI
0 Signals |
Accuracy: 0.00% | Accuracy
Buy: 0.00% | Accuracy
Sell: 0.00%
Avg return
buy: 0.00 % | Avg return
sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.